Concern over the withdrawal of innovative drugs from the Greek market
Great concern prevails in the health sector in Greece, as warnings from pharmaceutical companies regarding the withdrawal of new innovative drugs from our country are being confirmed. This issue is of great concern to both patients and healthcare professionals, as these treatments are essential for managing serious illnesses.
According to initial reports, pharmaceutical companies had warned for some time that conditions in the Greek market make it difficult to distribute certain new products. The reasons for this decision are related to economic factors and the pricing procedures followed in the country.
Experts express fears that this withdrawal will not be limited only to the drugs already announced. There is a serious risk that other products will follow, which could create significant gaps in the pharmaceutical coverage of Greek patients.
The situation is being closely monitored by the relevant authorities, who are seeking solutions to ensure citizens' access to necessary treatments. Further developments are expected in the coming period, as negotiations between the state and the companies remain ongoing.